Previous 10 | Next 10 |
4 Penny Stocks For Your Watchlist Right Now With a new month around the corner, there are plenty of penny stocks that investors are watching right now. This includes a specific spotlight on tech and biotech penny stocks . One thing to consider when investing in penny stocks in 2...
Should you buy penny stocks today ? If you like volatility, quick gains, handle high-risk situations and understand trading basics, I say, why not? But the stock market today isn’t like it was even just a year ago. The fact is, millions of new traders have flooded into the market...
9 Meters Biopharma (NMTR) has acquired global development rights to a proprietary and highly specific humanized monoclonal antibody (mAb), LOB-0136 (now known as NM-136) that targets glucose-dependent insulinotropic polypeptide ((GIP)), in addition to related intellectual property from privat...
- Broadens existing pipeline with a monoclonal antibody against a novel target, glucose-dependent insulinotropic polypeptide (GIP) - - First planned indication is Prader-Willi Syndrome- - IND-enabling studies ongoing with first-in-human studies anticipated in 2023 - - Transact...
Are These 3 Penny Stocks Worth Watching in 2021? With earnings season in full swing, there are plenty of penny stocks to watch right now. On Wednesday, July 14th, both blue chips and penny stocks ended the day mostly mixed. Several banks throughout the day reported relatively low-gr...
Gainers: Aerpio Pharmaceuticals (ARPO) +54%, GBS (GBS) +25%, 9 Meters Biopharma (NMTR) +19%, Alterity Therapeutics (ATHE) +10%, F-star Therapeutics (FSTX) +9%.Losers: Virpax Pharmaceuticals (VRPX) -13%, Nephros (NEPH) -12%, ...
naphtalina/iStock via Getty Images Talkspace initiated as outperform at Baird Baird has initiated online therapy provider Talkspace ([[TALK]] -8.4%) with an outperform rating and a $10 price target (~50% upside). Analyst Vikram Kesavabhotla says he expects to company to benefit from broader t...
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that John Temperato, CEO of 9 Meters Biopharma will participate in a virtual fireside chat at the William Blair Biot...
Why Execs Won’t Stop Talking About These 8 Penny Stocks When an insider buys a penny stock or any stock for the matter, it is often a good sign for investors. This shows both institutional confidence in a company and belief in its short or long-term future. But it’s worth ...
Why These Penny Stocks Could Be Worth Adding to Your Watchlist Finding the most trending penny stocks is something that has become commonplace in the past year. With the advent of social media investors, penny stocks on Reddit , Twitter, and more have become very popular in 2021. Ad...
News, Short Squeeze, Breakout and More Instantly...
9 Meters Biopharma Inc. Company Name:
NMTR Stock Symbol:
NASDAQ Market:
RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced that the Board of Directors has accepted the resignation of John Temperato as President ...
RALEIGH, NC / ACCESSWIRE / May 15, 2023 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2...
RALEIGH, NC / ACCESSWIRE / April 5, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced receipt of a written response from the U.S. Food and Drug Administration (FDA) on the r...